Chrysin, a flavonoid attenuates histological changes of hyperammonemic rats: A dose dependent study

Biomedicine and Pharmacotherapy

Volumn 82, Issue , 2016, Pages 345-354

  Renuka, Mani ^a   Vijayakumar, Natesan ^a   Ramakrishnan, Arumugam ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Chrysin; Histological changes; Hyperammonemia; Liver marker enzymes; Na+ K+ ATPase; NO

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMMONIA; AMMONIUM CHLORIDE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHRYSIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUTAMIC ACID; GLUTAMINE; NITRIC OXIDE; UREA; URIC ACID; BIOLOGICAL MARKER; FLAVONOID;

AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY WEIGHT; BRAIN TISSUE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; HISTOLOGY; HYPERAMMONEMIA; INTOXICATION; KIDNEY PARENCHYMA; LIPID PEROXIDATION; LIVER; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PURKINJE CELL; RAT; UREA BLOOD LEVEL; UREA CYCLE; URIC ACID BLOOD LEVEL; ANIMAL; BIOLOGICAL MODEL; BLOOD; BRAIN; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; KIDNEY; METABOLISM; PATHOLOGY; WISTAR RAT;

AMMONIA; ANIMALS; BILIRUBIN; BIOMARKERS; BODY WEIGHT; BRAIN; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; GLUTAMIC ACID; GLUTAMINE; HYPERAMMONEMIA; KIDNEY; LIVER; MALE; MODELS, BIOLOGICAL; NITRIC OXIDE; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; UREA; URIC ACID;

EID: 84969506394     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.05.013     Document Type: Article

References (52)

1. Felipo V., Butterworth R.F. Neurobiology of ammonia. Prog. Neurobiol. 2002, 67:259-279.
2. Gropman A.L., Batshaw M.L. Cognitive outcome in urea cycle disorders. Mol. Genet. Metab. 2004, 81:58-62.
3. Wilcken B. Problems in the management of urea cycle disorders. Mol. Genet. Metab. 2004, 81:86-91.
4. Cooper A.J., Lai J.C. Cerebral ammonia metabolism in normal and hyperammonemic rats. Neurochem. Pathol. 1987, 6:67-95.
5. Cooper A.J., Mora S.N., Cruz N.F., Gelbard A.S. Cerebral ammonia metabolism in hyperammonemic rats. J. Neurochem. 1985, 44:1716-1723.
6. Chung C., Gottstein J., Blei A.T. Indomethacin prevents the development of experimental ammonia induced brain edema in rats after portacaval anastomosis. Hepatology 2001, 34:249-254.
7. Norenberg M.D., Jayakumar A.R., Rama Rao K.V. Oxidative stress in the pathogenesis of hepatic encephalopathy. Metab. Brain Dis. 2004, 19:313-329.
8. +-ATPase of bulk isolated glial cells, perikarya and synaptosomes from rabbit brain cortex. Brain Res. 1979, 165:87-103.
9. Ericinska M., Silver I.A. Ions and energy in mammalian brain. Prog. Neurobiol. 1994, 43:37-71.
10. Wheller K.P., Walker J.A., Barker D.M. Lipid requirement of the membrane sodium-plus-potassium ion-dependent adenosine tri phosphatase system. Biochem. J. 1975, 146:713-722.
11. Cooper A.J.L., Plum F. Biochemistry and physiology of brain ammonia. Physiol. Rev. 1987, 67:440-519.
12. Dawson V.L., Dawson T.M. Nitric oxide actions in neurochemistry. Neurochem. Int. 1996, 29:97-110.
13. Dalkara T., Endres M., Moskowitz M.A. Mechanisms of NO neurotoxicity. Prog. Brain Res. 1998, 118:231-239.
14. Minana M.D., Corbalan R., Montoliu C., Teng C.M., Felipo V. Chronic hyperammonemia in rats impairs activation of soluble guanylate cyclase in neurons and in lymphocytes: a putative peripheral marker for neurological alterations. Biochem. Biophys. Res. Commun. 1999, 257:405-409.
15. Munoz M.D., Monfort P., Gaztelu J.M., Felipo V. Hyperammonemia impairs NMDA receptor dependent long term potentiation in the CA1 of rat hippocampus in vitro. Neurochem. Res. 2000, 25:437-441.
16. Kosenko E., Kaminsky Y., Stavroskaya I.G., Felipo V. Alteration of mitochondrial calcium homeostasis by ammonia-reduced activation of NMDA receptors in rat brain in vivo. Brain Res. 2000, 880:139-146.
17. Maulik N., McFadden D., Otani H., Thirunavukkarasu M., Parinandi N.L. Antioxidants in longevity and medicine. Oxid. Med. Cell Longev. 2013, 1-3.
18. Kosenko E., Llansola M., Montoliu C., Monfort P., Rodrigo R., Hernandez-Viadel M., Erceg S., Sanchez-Perez A.M., Felipo V. Glutamine synthetase activity and glutamine content in brain: modulation by NMDA receptors and nitric oxide. Neurochem. Int. 2003, 43:493-499.
19. Opez-Alarc ona C.L., Denicola A. Evaluating the antioxidant capacity of natural products: a review on chemical and cellular-based assays. Anal. Chim. Acta. 2013, 763:1-10.
20. Mathias R.S., Kostiner D., Packman S. Hyperammonemia in urea cycle disorders: role of the nephrologist. Am. J. Kidney Dis. 2001, 37:1069-1080.
21. Mandel S.A., Amit T., Weinreb O., Reznichenko L., Youdim M.B. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci. Ther. 2008, 14:352-365.
22. Barbaric M., Miskovic K., Bojic M., Loncar M.B., Smolcic-Bubalo A., Debeljak Z., Saric M. Chemical composition of the ethanolic propolis extracts and its effect on HeLa cells. J. Ethnopharmacol. 2011, 135:772-778.
23. Wolfman C., Violah Paladini A., Dajas F., Medina J.H. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol. Biochem. 1994, 47:1-4.
24. Vijayakumar N., Subramanian P. Protective effect of semecarpus anacardium nut extract against hyperammonemia in rats. J. Hospitality Manage. Tourism 2010, 4:77-82.
25. 2+-ATPase activities induced by the in vitro galactosaemia. Pharmacol. Res. 2004, 49:475-479.
26. Wolheim D.F. Preanalytical increase of ammonia in blood specimens from healthy subjects. Clin. Chem. 1984, 30:906-908.
27. Varley H., Gowenlock A.H., Bell M. Practical Clinical Biochemistry 1998, vol. 1:161-210. CBS Publishers, New Delhi. 4th edn.
28. Bonsnes R.W., Taussky H.H. On the colorimetric determination of creatinine by the Jaffee reaction. J. Biol. Chem. 1945, 158:581-591.
29. Malloy H.T., Evelyn K.A. The determination of bilirubin with the photoelectric colorimeter. J. Biol. Chem. 1937, 119:481.
30. Lin C.C., Hus Y.F., Lin T.C., Hsu F.L., Hus H.Y. Antioxidant and hepatoprotective activity of punica lagin-induced liver damage in rats. J. Pharmacol. 1998, 50:789-794.
31. Lund P., Bergmeyer H.U., 1985. l-glutamine and l-glutamate UV-method with glutaminase and glutamate dehydrogenase 8; 357-363.
32. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.K., Tannenbaum S.R. Analysis of nitrate, nitrite and 15N in biological fluids. Anal. Biochem. 1982, 126:131-136.
33. Fiske C.H., Subbarow Y. The calorimetric determination of phosphorous. J. Biol. Chem. 2004, 98:159-162.
34. Reitman S., Franke A.S. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. 1957, 28:56-63.
35. King E., Armstrong A.R. Determination of serum and bile phosphatase activity. Can. Med. Assoc. J. 1951, 31:376-378.
36. Plum F. The CSF in hepatic encephalopathy. Exp. Biol. Med. 1971, 4:34-41.
37. Duffy T.E., Plum F. Hepatic encephalopathy. The Liver: Biology and Pathobiology 1982, 693-715. Raven Press, New York.
38. Felipo V. Hyperammonemia. Handbook of Neurochemistry and Molecular Neurobiology 2008, vol. 24:1-27. Kluwer Academic/Plenum Publishers, USA. 3rd edition.
39. Nakamura Y., Torikai K., Ohigashi H. Toxic dose of a simple phenolic antioxidant protocatechuic acid, attenuates the glutathione level in ICR mouse liver and kidney. J. Agric. Food Chem. 2001, 49:5674-5678.
40. Shirwaikar A., Malini S., Kumari S.C. Protective effect of Pongamia pinnata flowers against cisplatin and gentamicin induced nephrotoxicity in rats. Ind. J. Exp. Biol. 2003, 41:58-62.
41. Baynes J.W. Reactive oxygen in the aetiology and complications of diabetes. Drug Diet and Disease, Mechanistic Approach to Diabetes 1995, vol. 2:230-231. Ellis Horwood limited, Hertfortshive.
42. Chen T., Subeq Y., Lee R., Chiou T., Hsu B. Single dose intravenous thioacetamide administration as a model of acute liver damage in rats. Int. J. Exp. Pathol. 2008, 89:223-231.
43. Rehman M.U., Tahir M., Khan A.Q., Khan R., Lateef A., Oday O.H., Qamar W., Ali F., Sultana S. Chrysin suppresses renal carcinogenesis via amelioration of hyperproliferation, oxidative stress and inflammation: plausible role of NF-kappa-B. Toxicol. Lett. 2013, 216:146-158.
44. Willard-Mack C.L., Koehler R.C., Hirata T., Cork L.C., Takahashi H., Traystman R.J., Brusilow S.W. Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat. Neuroscience 1996, 71:589-599.
45. Blei A.T. Cerebral edema and intracranial hypertension in acute liver failure: distinct aspects of the same problem. Hepatology 1991, 13:376-379.
46. Subramanian P., Jayakumar M., Jayapalan J.J., Hashim O.H. Chronotherapeutic effect of fisetin on expression of urea cycle enzymes and inflammatory markers in hyperammonaemic rats. Pharmacol. Rep. 2014, 66:1037-1042.
47. Llansola M., Ahabrach H., Errami M., Cabrera-Pastor A., Addaoudi K., Felipo V. Impaired release of corticosterone from adrenals contribute to impairment of circadian rhythms of activity in hyperammonemic rats. Arch. Biochem. Biophys. 2013, 536:164-170.
48. Jayakumar A.R., Panicka K.S., Murthy C., Norenberg M.D. Oxidative stress and MAPK phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J. Neurosci. 2006, 26:4774-4784.
49. Sadasivudu B., lndira Rao T., Murthy C.R.K. Acute metabolic effects of ammonia in mouse brain. Neurochem. Res. 1977, 2:639-655.
50. Kucera O., Lotkova H., Stankova P., Podhola M., Rousar T., Mezera V., Cervinkova Z. Is rat liver affected by non-alcoholic steatosis more susceptible to the acute toxic effect of thioacetamide?. Int. J. Exp. Pathol. 2011, 92:281-289.
51. Farjam M., Dehdab P., Abbassnia F., Mehrabani D., Tanideh N., Pakbaz S., Imanieh M.H. Thioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes. Iran. Red Crescent Med. J. 2012, 164-170.
52. Samundeeswari N., Rajadurai M., Ganapathy P., Rexlin Shairibha S. Effect of vimliv on lipid profile and histopathology in ethanol-induced hepatotoxicity in albino Wistar rats. Int. J. Nutr. Pharmacol. Neurol. Dis. 2013, 3:114-120.